FDA Advisers Back Pill to Help Prevent HIV Infection

<p>THURSDAY, May 10 (HealthDay News) U.S. Food and Drug
Administration advisers permitted Thursday a use of a drug Truvada as a
means to assistance forestall HIV infection in healthy people during high risk of
contracting a AIDS-causing virus.
In a array of votes that could lead to capitulation of a vital new weapon
in a quarrel opposite AIDS, a FDA advisers endorsed capitulation of the
daily tablet for healthy, at-risk individuals, including happy and bisexual
men and heterosexual couples with one HIV-infected person, the
Associated Press reported.
The FDA is not firm to follow a recommendations of a advisory
panels, though it typically does so. A final preference is approaching by
mid-June.
A news expelled progressing this week by a FDA suggested that
scientists trust a drug is stable and effective.
But there are intensity drawbacks to regulating a remedy as a proceed to
combat HIV infection. Truvada that combines dual HIV-fighting drugs,
tenofovir (Viread) and emtricitabine ...